Susumu Tsujimoto

571 total citations
36 papers, 502 citations indexed

About

Susumu Tsujimoto is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Susumu Tsujimoto has authored 36 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Susumu Tsujimoto's work include Renal Transplantation Outcomes and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer therapeutics and mechanisms (3 papers). Susumu Tsujimoto is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer therapeutics and mechanisms (3 papers). Susumu Tsujimoto collaborates with scholars based in Japan, Israel and United States. Susumu Tsujimoto's co-authors include Toshitaka Manda, Ikuo Kawamura, Kyoichi Shimomura, Masamichi Inami, Fusako Nishigaki, Yoshinori Naoe, Masaaki Tomoi, Ryuichi Morishita, Toshio Ogihara and Sanae Matsumoto and has published in prestigious journals such as British Journal of Pharmacology, European Journal of Pharmacology and Transplantation.

In The Last Decade

Susumu Tsujimoto

36 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susumu Tsujimoto Japan 14 261 95 90 73 70 36 502
Tanya L. Wallace United States 10 293 1.1× 61 0.6× 88 1.0× 70 1.0× 32 0.5× 11 479
Draginja Djurickovic United States 6 179 0.7× 71 0.7× 45 0.5× 70 1.0× 61 0.9× 8 359
Kaoru Terai United States 14 254 1.0× 25 0.3× 77 0.9× 51 0.7× 37 0.5× 25 477
Hayoung Hwang South Korea 13 210 0.8× 53 0.6× 46 0.5× 21 0.3× 87 1.2× 28 423
Afshin Bahador United States 10 314 1.2× 37 0.4× 47 0.5× 21 0.3× 42 0.6× 19 496
E Chinje United Kingdom 8 195 0.7× 84 0.9× 52 0.6× 138 1.9× 13 0.2× 11 394
Silvi Luell United States 15 265 1.0× 99 1.0× 106 1.2× 28 0.4× 116 1.7× 21 590
Wasia Rizwani United States 14 624 2.4× 67 0.7× 53 0.6× 142 1.9× 68 1.0× 16 926
Jim D. Durbin United States 11 239 0.9× 33 0.3× 96 1.1× 41 0.6× 16 0.2× 16 445
Sharon Y. James United Kingdom 14 327 1.3× 39 0.4× 30 0.3× 79 1.1× 45 0.6× 20 615

Countries citing papers authored by Susumu Tsujimoto

Since Specialization
Citations

This map shows the geographic impact of Susumu Tsujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susumu Tsujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susumu Tsujimoto more than expected).

Fields of papers citing papers by Susumu Tsujimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susumu Tsujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susumu Tsujimoto. The network helps show where Susumu Tsujimoto may publish in the future.

Co-authorship network of co-authors of Susumu Tsujimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Susumu Tsujimoto. A scholar is included among the top collaborators of Susumu Tsujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susumu Tsujimoto. Susumu Tsujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Misato, et al.. (2019). The PI3Kδ selective inhibitor AS2541019 suppresses donor-specific antibody production in rat cardiac and non-human primate renal allotransplant models. International Immunopharmacology. 75. 105756–105756. 5 indexed citations
2.
Kobayashi, Miki, Yoshiyuki Tenda, Susumu Tsujimoto, et al.. (2013). Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of “chemoattractant receptor homologous molecule expressed on Th2 cells” (CRTH2). European Journal of Pharmaceutical Sciences. 49(3). 434–440. 8 indexed citations
3.
Kuno, Masako, Nobuo Seki, Susumu Tsujimoto, et al.. (2006). Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938. European Journal of Pharmacology. 534(1-3). 241–249. 39 indexed citations
4.
Inami, Masamichi, Ikuo Kawamura, Susumu Tsujimoto, et al.. (2002). Effects of FK317, a novel anti-cancer agent, on survival of mice bearing B16BL6 melanoma and Lewis lung carcinoma. Cancer Letters. 181(1). 39–45. 15 indexed citations
5.
Tsujimoto, Susumu, Ikuo Kawamura, Masamichi Inami, et al.. (2000). Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.. PubMed. 20(5A). 3111–6. 10 indexed citations
6.
Kawamura, Ikuo, Elizabeth P. Lacey, N. Yamamoto, et al.. (2000). Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.. PubMed. 19(5B). 4105–11. 13 indexed citations
7.
Kawamura, Ikuo, Ryuichi Morishita, Naohiro Tomita, et al.. (1999). Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model. Gene Therapy. 6(1). 91–97. 102 indexed citations
8.
Naoe, Yoshinori, Masamichi Inami, Ikuo Kawamura, et al.. (1998). Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity. Japanese Journal of Cancer Research. 89(6). 666–672. 22 indexed citations
9.
Naoe, Yoshinori, Masamichi Inami, Fusako Nishigaki, et al.. (1998). FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome. Cancer Chemotherapy and Pharmacology. 42(1). 31–36. 38 indexed citations
10.
Naoe, Yoshinori, Masamichi Inami, Sanae Matsumoto, et al.. (1998). Different Effects of FK317 on Multidrug‐resistant Tumor in vivo and in vitro. Japanese Journal of Cancer Research. 89(10). 1047–1054. 16 indexed citations
11.
Yamamoto, N., Ikuo Kawamura, Fusako Nishigaki, et al.. (1998). Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice.. PubMed. 18(1A). 139–44. 18 indexed citations
12.
Naoe, Yoshinori, Masamichi Inami, Sanae Matsumoto, et al.. (1998). FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice. Japanese Journal of Cancer Research. 89(12). 1306–1317. 21 indexed citations
13.
Naoe, Yoshinori, Ikuo Kawamura, Masamichi Inami, et al.. (1998). Anti‐cachectic Effect of FK317, a Novel Anti‐cancer Agent, in Colon26 and LX‐1 Models in Mice. Japanese Journal of Cancer Research. 89(12). 1318–1325. 20 indexed citations
14.
Inami, Masamichi, Ikuo Kawamura, Yoshinori Naoe, et al.. (1997). Effects of a New Non-Steroidal 5.ALPHA.-Reductase Inhibitor, FK143, on the Prostate Gland in Beagle Dogs.. The Japanese Journal of Pharmacology. 74(2). 187–194. 4 indexed citations
15.
Kawamura, Ikuo, Elizabeth P. Lacey, Fusako Nishigaki, et al.. (1995). A New Aromatase Inhibitor, FR901537. II. Pharmacological and Antitumor Effects.. The Journal of Antibiotics. 48(8). 763–767. 2 indexed citations
16.
Nishigaki, Fusako, Kikuo Miyayasu, Susumu Tsujimoto, Toshitaka Manda, & Kyoichi Shimomura. (1995). Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.. PubMed. 14(6B). 2573–6. 1 indexed citations
17.
Tsujimoto, Susumu, et al.. (1993). Effects of intracerebroventricular injection of histamine and related compounds on corticosterone release in rats. British Journal of Pharmacology. 109(3). 807–813. 16 indexed citations
18.
19.
20.
Kamei, Chiaki, Susumu Tsujimoto, & Kenjí Tasaka. (1990). Effects of cholinergic drugs and cerebral metabolic activators on memory impairment in old rats.. Journal of Pharmacobio-Dynamics. 13(12). 772–777. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanya L. Wallace Breakdown of academic impact, for papers by Draginja Djurickovic Breakdown of academic impact, for papers by Kaoru Terai Breakdown of academic impact, for papers by Hayoung Hwang Breakdown of academic impact, for papers by Afshin Bahador Breakdown of academic impact, for papers by E Chinje Breakdown of academic impact, for papers by Silvi Luell Breakdown of academic impact, for papers by Wasia Rizwani Breakdown of academic impact, for papers by Jim D. Durbin Breakdown of academic impact, for papers by Sharon Y. James
Rankless by CCL
2026